NIH awards $27M for Biomedical R&D to Regents of the University of California, San Francisco over 10 years
Contract Overview
Contract Amount: $27,000,107 ($27.0M)
Contractor: Regents of the University of California, SAN Francisco, the
Awarding Agency: Department of Health and Human Services
Start Date: 2002-07-01
End Date: 2012-12-31
Contract Duration: 3,836 days
Daily Burn Rate: $7.0K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: COST NO FEE
Sector: R&D
Official Description: BIOMEDICAL (APPLIED/EXPLORATORY)
Place of Performance
Location: SAN FRANCISCO, SAN FRANCISCO County, CALIFORNIA, 94118, UNITED STATES OF AMERICA
Plain-Language Summary
Department of Health and Human Services obligated $27.0 million to REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE for work described as: BIOMEDICAL (APPLIED/EXPLORATORY) Key points: 1. Significant long-term investment in biomedical research. 2. Competition was full and open, suggesting potential for competitive pricing. 3. Risk is moderate given the long duration and research nature. 4. Sector focus is R&D, a critical area for innovation.
Value Assessment
Rating: good
The contract's 'COST NO FEE' structure indicates that the government reimburses actual costs without an additional fee. This is common in research grants where the focus is on supporting the research itself rather than profit.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, which generally promotes competitive pricing. However, the 'COST NO FEE' structure means the government bears the direct costs of the research, with the primary price discovery mechanism being the proposed research budget.
Taxpayer Impact: Taxpayer funds are directly supporting critical biomedical research, with the potential for significant long-term health and economic benefits.
Public Impact
Supports cutting-edge biomedical research with potential for major health breakthroughs. Long-term funding provides stability for research projects and personnel. Investment in a leading research institution like UCSF. Potential for advancements in disease treatment and prevention.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Long contract duration increases exposure to changing research needs.
- Cost-reimbursement contracts can sometimes lead to less stringent cost control.
Positive Signals
- Supports critical R&D in a high-impact sector.
- Full and open competition suggests a robust selection process.
- Funding a leading research institution.
Sector Analysis
This contract falls within the Biomedical R&D sector, specifically focusing on applied and exploratory research. Spending in this area is crucial for scientific advancement and public health, with benchmarks often tied to NIH funding levels and institutional research expenditures.
Small Business Impact
This award was made to a large university system and does not appear to directly involve small businesses as prime contractors. Subcontracting opportunities for small businesses may exist but are not explicitly detailed in this award information.
Oversight & Accountability
The National Institutes of Health (NIH) is responsible for overseeing this award. Oversight would typically involve monitoring research progress, adherence to grant terms, and financial accountability to ensure funds are used effectively for the stated research objectives.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Long contract duration (10 years).
- Cost reimbursement contract type ('COST NO FEE').
- Research scope is broad ('APPLIED/EXPLORATORY').
- Potential for scope creep over the award period.
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, ca, dca, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $27.0 million to REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE. BIOMEDICAL (APPLIED/EXPLORATORY)
Who is the contractor on this award?
The obligated recipient is REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $27.0 million.
What is the period of performance?
Start: 2002-07-01. End: 2012-12-31.
What is the specific research focus of this $27M award, and what are the expected outcomes?
The specific research focus is not detailed in the provided data, but it falls under 'Research and Development in the Physical, Engineering, and Life Sciences' for 'BIOMEDICAL (APPLIED/EXPLORATORY)'. Expected outcomes would likely include scientific publications, new discoveries, potential therapeutic targets, or advancements in understanding biological processes, contributing to the broader goals of the National Institutes of Health.
Given the 'COST NO FEE' structure and long duration, what are the primary risks to the government regarding cost control and research relevance?
The primary risk to cost control is the potential for unmonitored or inefficient spending, as the government reimburses actual costs without a profit incentive for the contractor to minimize expenses. Research relevance risk stems from the long duration; scientific priorities can shift, potentially making the original research objectives less critical or feasible by the end of the award period.
How does this award contribute to the overall effectiveness of the NIH's mission in advancing biomedical science?
This award contributes to the NIH's mission by funding critical, long-term research at a leading institution. By supporting exploratory and applied biomedical science, it fosters innovation and the potential for significant breakthroughs in health and medicine, aligning with the NIH's goal of improving human health through research.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 1
Pricing Type: COST NO FEE (S)
Evaluated Preference: NONE
Contractor Details
Parent Company: State of California Controllers Office (UEI: 071549000)
Address: 1855 FOLSOM ST STE 425, SAN FRANCISCO, CA, 94103
Business Categories: Category Business, Educational Institution, Government, Higher Education, Nonprofit Organization, Not Designated a Small Business, U.S. Regional/State Government, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $124,809,690
Exercised Options: $30,336,429
Current Obligation: $27,000,107
Timeline
Start Date: 2002-07-01
Current End Date: 2012-12-31
Potential End Date: 2015-10-14 00:00:00
Last Modified: 2016-09-12
More Contracts from Regents of the University of California, SAN Francisco, the
- Novation From Cpic to Ucsf Effect. 8/01/18--Surveillance, Epidemiology, and END Results (seer) Program, POP: 05/01/2018-04/30/2028 — $36.9M (Department of Health and Human Services)
- Sexually Transmitted Infections Clinical Trials Group — $26.6M (Department of Health and Human Services)
- Biomedical (basic) — $22.0M (Department of Health and Human Services)
- Biomedical (applied/Exploratory) — $16.2M (Department of Health and Human Services)
- R&d-Other R & D-B RES — $13.6M (Department of Health and Human Services)
View all Regents of the University of California, SAN Francisco, the federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →